$88.5 Million is the total value of Telemetry Investments, L.L.C.'s 126 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EUFN | ISHARES TRmsci euro fl etf | $1,445,000 | +9.8% | 75,000 | 0.0% | 1.63% | -26.5% | |
| FEZ | SPDR INDEX SHS FDSeuro stoxx 50 | $1,424,000 | +6.7% | 32,000 | 0.0% | 1.61% | -28.6% | |
| FXI | ISHARES TRchina lg-cap etf | $933,000 | +0.4% | 20,000 | 0.0% | 1.06% | -32.8% | |
| XLF | SELECT SECTOR SPDR TRsbi int-finl | $851,000 | +15.5% | 25,000 | 0.0% | 0.96% | -22.7% | |
| INDA | ISHARES TRmsci india etf | $801,000 | +4.8% | 19,000 | 0.0% | 0.91% | -29.8% | |
| SAN | BANCO SANTANDER S.A.adr | $716,000 | +12.4% | 208,695 | 0.0% | 0.81% | -24.8% | |
| WFC | WELLS FARGO CO NEW | $664,000 | +29.4% | 17,000 | 0.0% | 0.75% | -13.4% | |
| EWW | ISHARES INCmsci mexico etf | $614,000 | +2.0% | 14,000 | 0.0% | 0.69% | -31.8% | |
| DXJ | WISDOMTREE TRjapn hedge eqt | $613,000 | +12.7% | 10,000 | 0.0% | 0.69% | -24.6% | |
| EWZ | ISHARES INCmsci brazil etf | $535,000 | -9.8% | 16,000 | 0.0% | 0.60% | -39.6% | |
| EEM | ISHARES TRmsci emg mkt etf | $533,000 | +3.1% | 10,000 | 0.0% | 0.60% | -31.0% | |
| GLD | SPDR GOLD TR | $480,000 | -10.3% | 3,000 | 0.0% | 0.54% | -39.9% | |
| BP | BP PLCsponsored adr | $341,000 | +18.8% | 14,000 | 0.0% | 0.39% | -20.4% | |
| TTE | TOTAL SEsponsored ads | $279,000 | +11.2% | 6,000 | 0.0% | 0.32% | -25.7% | |
| E | ENI S P Asponsored adr | $272,000 | +19.8% | 11,000 | 0.0% | 0.31% | -19.8% | |
| MSFT | MICROSOFT CORP | $212,000 | +6.0% | 900 | 0.0% | 0.24% | -29.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | 33 | Q4 2022 | 1.7% |
| AFFIMED N V | 31 | Q4 2022 | 3.9% |
| GLOBALSTAR INC | 30 | Q4 2022 | 2.5% |
| VIEWRAY INC | 23 | Q4 2022 | 2.1% |
| SPDR GOLD TRUST | 22 | Q4 2022 | 2.3% |
| ADMA BIOLOGICS INC | 21 | Q4 2022 | 2.9% |
| STEMLINE THERAPEUTICS INC | 21 | Q1 2020 | 1.2% |
| SPDR S&P 500 ETF TR | 20 | Q4 2022 | 53.9% |
| KADMON HLDGS INC | 19 | Q2 2021 | 7.0% |
| EIGER BIOPHARMACEUTICALS INC | 19 | Q4 2022 | 6.7% |
View Telemetry Investments, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Xtant Medical Holdings, Inc. | February 13, 2020 | 752,915 | 5.7% |
| Orexigen Therapeutics, Inc. | February 14, 2019 | 1,295,844 | 6.4% |
| Xtant Medical Holdings, Inc. | February 14, 2018 | 1,416,339 | 7.2% |
View Telemetry Investments, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-17 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
View Telemetry Investments, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.